Oral squamous cell carcinoma (OSCC) is the most common form of head and neck cancer, and the number of new cases is predicted ...

AUSTIN — A novel pragmatic classification system (PCS) that considers resectability and high-stage tumors may be a more clinically useful staging paradigm for advanced cutaneous squamous cell ...

Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or non­melanoma skin cancer, which is also known as keratinocyte ...

Libtayo's FDA approval offers an effective adjuvant option for high-risk cutaneous squamous cell carcinoma, reducing recurrence risk by 68% in the C-POST trial. Administered post-surgery and radiation ...

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the combination of the immunotherapy drug avelumab and targeted agent cetuximab had ...

The C-POST trial showed a disease-free survival benefit with adjuvant Libtayo for high-risk cutaneous squamous cell carcinoma, potentially influencing future standard care. Immunotherapy remains the ...

Podium presentation at the American Head and Neck Society (AHNS) 12th International Conference on Head and Neck Cancer to report results from a ...

Pelareorep FDA Fast Track designation opens a registrational path for a viral immunotherapy targeting advanced anal cancer ...